Pharmaceutical Mylan pays up to $ 335 million for the Opyoid crisis in the United States
The company has been accused of marketing and sold opiative treatments since 2005, which has contributed to the high prescription and deviation of the illegal market.
Jose A. Bernat Botty/Gettyemes
American Generic Medicines Company has agreed to pay up to $ 335 million to the United States for his role in the Opiat crisis, killing millions of people in the country since 1999.
“Mylan has safely betrayed its opiative-based treatments, although it sold it illegally,” said New York Attorney General Letitia James in a statement.
The company has reached an agreement to pay $ 335 million (about 306 million euros) in nine years with fifteen US State prosecutors led by the New York State.
The company has been accused of manufacturing and sold and sold various opiates since 2005, including Fentanil, Axicodone, Hydrocodone and Bupranorphine’s general adhesives.
“The company has given food to the Opiates crisis through direct marketing with doctors, which led to a dangerous high prescription and their opioids to deviate to the illegal drug market.”
The action was brought by California, Illinois, Massachusetts, North Carolina, Tennessee, Utah and Virginia in coordination with Colorado, Delaware, Georgia, Idaho, Iowa and Vermont lawyers.
Merger with the Laboratory Upizon made in 2020 – the branch of the Phizer, which specializes in non -patent -free drugs – to become Vietris.
To date, the Public Prosecution Service has grossed over $ 3 billion for companies that are connected to this crisis, such as CE Shadial laboratories – Purdue Pharma, which hopes to inspire crisis – but a branch like CVGs, Walmart, French Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public Public
On January 24, the US Laboratory Peruda Pharma signed an agreement with the fifteen US states, and they had to pay a total of $ 7.4 billion for their role in the opioid crisis.
New York’s same prosecutor reported in a statement, the deal, the owner of the CE Shadha, the owner of the CE Shadha, to pay up to $ 6.5 billion in fifteen years and 900 million CEist.
According to the data of the disease control and prevention centers (CDC, English Acronim), about 727,000 people have died in the country between 1999 and 2022 because of the intake of opioids or illegally obtained opioids.
For the first time after 2018, the number of deaths connected to opioids (mainly Fentanil) has been slightly reduced by 2023.
